Cours Scythian Biosciences Corp Canadian Securities Exchange
Actions
CA7840531007
Gestion des placements et exploitants de fonds
CA 2022 | -235,54 -321,94 -214,98 | CA 2023 | -31,51 -43,07 -28,76 | Capitalisation | 6,26 M 8,56 M 5,71 M |
---|---|---|---|---|---|
Résultat net 2022 | -297 M -406 M -271 M | Résultat net 2023 | -34 M -46,47 M -31,03 M | VE / CA 2022 | -188 347 x |
Dette nette 2022 | 24,76 M 33,85 M 22,6 M | Trésorerie nette 2023 | 70,4 M 96,22 M 64,25 M | VE / CA 2023 | 2 035 264 x |
PER 2022 |
-0,07
x | PER 2023 |
-0,18
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 91,99% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Paul Kania
CEO | Chief Executive Officer | - | 19/05/20 |
Deena Siblock
BRD | Director/Board Member | - | 27/02/23 |
Corporate Officer/Principal | - | 17/04/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mehdi Azodi
BRD | Director/Board Member | - | 27/02/23 |
Deena Siblock
BRD | Director/Board Member | - | 27/02/23 |
Jason Batista
BRD | Director/Board Member | - | 07/06/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+3,65% | 31,94 Md | |
0,00% | 17,45 Md | |
+6,42% | 5,54 Md | |
-0,42% | 3,08 Md | |
+15,23% | 2,98 Md | |
+22,64% | 2,9 Md | |
-18,98% | 2,24 Md | |
+4,02% | 1,23 Md | |
-2,00% | 1,07 Md |